India considers annual random drug tests for all commercial pilots

Following a mid-air incident involving an Air India captain who subsequently tested positive for marijuana, the Indian government is evaluating a mandate requiring every commercial pilot to undergo a random drug test at least once a year. Civil Aviation Minister Ram Mohan Naidu Kinjarapu confirmed Tuesday that the Directorate General of Civil Aviation (DGCA) is consulting stakeholders to overhaul existing psychoactive substance screening protocols.

Under the current framework, regulations stipulate that only 10% of a carrier's overall pilot network is subjected to random screening annually. Authorities are now exploring a significant expansion to cover 100% of the workforce, keeping the timing of these evaluations entirely unpredictable to maintain aviation safety. A robust domestic airline industry relies heavily on passenger trust, and recent lapses have forced regulators to scrutinize operational vigilance. Naidu noted that while establishing a stricter policy is paramount, the government is carefully balancing enhanced safety protocols with the operational realities facing airlines.

The proposed regulatory shift stems directly from the August 4 scare on an Air India flight from Phuket to Delhi. The Airbus A320neo experienced a sudden loss of roughly 300 feet in altitude during cruise, injuring at least 17 individuals on board. A post-flight confirmatory evaluation of the pilot-in-command returned a positive result for marijuana.

In response to the alarming incident, the Air India group proactively initiated a one-time mandatory screening exercise covering its approximately 5,000 pilots, exceeding current minimum regulatory requirements. During this initial sweep, two additional pilots reportedly returned "non-negative" results, leading to their immediate grounding pending confirmatory laboratory analysis. The Aircraft Accident Investigation Bureau (AAIB) continues its probe into the August 4 event, while pilot unions advocate for quicker, saliva-based testing methods to streamline future compliance.